PIIND2021-01-012021-03-31in-bse-fin:OneOperatingExpenses01Member PIIND2021-01-012021-03-31in-bse-fin:FourOperatingExpenses01Member PIIND2021-01-012021-03-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member PIIND2021-01-012021-03-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member PIIND2021-01-012021-03-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member PIIND2021-01-012021-03-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss02Member PIIND2021-01-012021-03-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member PIIND2021-01-012021-03-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares PIIND 2020-04-01 2021-03-31 2021-05-10 INR Millions Yearly true Cash Flow Indirect Single segment Agri 2021-01-01 2021-03-31 Audited Consolidated 11971000000.00 442000000.00 12413000000.00 7553000000.00 124000000.00 -747000000.00 1096000000.00 44000000.00 448000000.00 1671000000.00 10189000000.00 2224000000.00 0.00 2224000000.00 450000000.00 -25000000.00 425000000.00 0.00 1799000000.00 0.00 0.00 0.00 -1000000.00 1798000000.00 -7000000.00 1791000000.00 1791000000.00 0.00 1791000000.00 0.00 152000000.00 1 11.96 11.95 0.00 0.00 11.96 11.95 1. The above Consolidated financial results were reviewed and recommended by the Audit Committee of the Board and approved by the Board of Directors at their meeting held on Mav 18. 2021 2. Consolidated Financial Results for all the period presented have been prepared in accoraance with recognition and measurement pnnciples of Ind AS notified under tne Companies (Indian Accounting Standards) Rules, 2015 as amended from time to time. 3. The Consolidated financial results include the results of the following entities namely, Subsidiaries a) PILL Finance and Investment Limited b) PI Life Science Research Limited c) PI Japan Co. Limited d) lsagro (Asia) Agrochemicals Private Limited e) Jivagro Limited f) PI Enzachem Private Limited. g) PI Fermachem Private Limited ; Controlled Trust. h) PII ESOP Trust; Equity accounted entities: i) PI Kumiai Private Limited (Joint Venture) j) Solin nos Agro Sciences Private Limited (Associate).4. The Figures for the last quarter are the balancing figures between audited figures in respect of full financial year and the published unaudited year to date figures upto the third quarter of the current financial year. 5. The Company is in the business of manufacturing and distribution of Agro Chemicals and accordingly has one reportable business segment viz. Agro Chemicals. 6. In management's evaluation, there is no significant impact of the COVID-19 pandemic on current and future business condition of the Company, liquidity position and cash flow and therefore, no material adjustments are required in the financial results. Management will continue to closely monitor the situation. 7. The Company has raised 20,000 million in July 2020 through Qualified Institutional Placement (QIP) of equity shares. The Company has issued 13,605,442 equity shares of face value of Re.1 each at a price Rs.1,470 per Equity Share, including a premium of rs.1,469 per Equity Share. Funds received pursuant to QIP ( net of expenses of Rs.250 million) remain invested in fixed deposits amounting to Rs.12,691 million and debt mutual funds of Rs.7,059 (liquid and other short term categories). 8. The previous period's fiqures have been reqrouped/ rearranqed/ reclassified wherever necessary. 9. The Board of Directors at their meeting held on May 18, 2021 have recommended final dividend of Rs.2.00 per equity share, subject to the approval of the shareholders in the ensuring Annual General Meeting. With this, total dividend for the year (including interim dividend of Rs.3.00 per equity share paid during the year) is Rs.5.00 per share. 10. Consolidated statement of cash flows is attached in Annexure I. 11. Disclosure required as 'large corporate' under SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018 . The Company is not a Large Corporate as on March 31 , 2021 as per the framework and applicability criteria given under the SEBI Circular. Single segment 2020-04-01 2021-03-31 Audited Consolidated 45770000000.00 1249000000.00 47019000000.00 25081000000.00 1637000000.00 -1006000000.00 4169000000.00 282000000.00 1748000000.00 5767000000.00 37678000000.00 9341000000.00 0.00 9341000000.00 1753000000.00 249000000.00 2002000000.00 0.00 7339000000.00 0.00 0.00 0.00 44000000.00 7383000000.00 698000000.00 8081000000.00 8081000000.00 0.00 8081000000.00 0.00 152000000.00 1 53272000000.00 49.92 49.89 0.00 0.00 49.92 49.89 Others 1671000000.00 Others 5767000000.00 282000000.00 -2539000000.00 -647000000.00 0.00 -981000000.00 46000000.00 -9000000.00 185000000.00 -36000000.00 2197000000.00 0.00 155000000.00 0.00 1748000000.00 0.00 -39000000.00 -28000000.00 335000000.00 19000000.00 -311000000.00 0.00 541000000.00 -31000000.00 -188000000.00 0.00 0.00 0.00 -62000000.00 0.00 -445000000.00 8896000000.00 0.00 0.00 0.00 1647000000.00 0.00 7249000000.00 0.00 0.00 15000000.00 0.00 0.00 0.00 0.00 0.00 15000000.00 4390000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 230000000.00 0.00 -20173000000.00 0.00 -24303000000.00 0.00 0.00 19750000000.00 0.00 0.00 0.00 39000000.00 0.00 1145000000.00 2931000000.00 248000000.00 0.00 607000000.00 244000000.00 0.00 0.00 16904000000.00 -150000000.00 0.00 -150000000.00 1246000000.00 1096000000.00